CAAS
NVAX icon

Capital Asset Advisory Services’s Novavax NVAX Stock Holding History

Capital Asset Advisory Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$22K – 1220
2020
Q4 		$22K Buy
+200
New +$21.3K ﹤0.01% 842

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Asset Advisory Services's NVAX Position: Q1 2021 in Review

Capital Asset Advisory Services sold out of Novavax (NVAX) in Q1 2021, closing a stake of 200 shares — an estimated $22K sold.

Capital Asset Advisory Services first reported a position in NVAX in Q4 2020 and held it in 1 quarter. The position peaked at $22K in Q4 2020. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • Capital Asset Advisory Services reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
  • Capital Asset Advisory Services sold 200 Novavax shares in Q1 2021, an estimated $22K.
  • Capital Asset Advisory Services first reported a position in Novavax in Q4 2020 and held it in 1 quarter.
  • Capital Asset Advisory Services's Novavax position peaked at $22K in Q4 2020.
  • 389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.